HomePHXM • EPA
add
Phaxiam Therapeutics SA
Previous close
€1.79
Day range
€1.76 - €1.80
Year range
€1.50 - €3.90
Market cap
17.75M EUR
Avg Volume
9.49K
P/E ratio
-
Dividend yield
-
Primary exchange
EPA
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 546.50K | 293.17% |
Operating expense | 5.88M | 26.86% |
Net income | -5.32M | 12.84% |
Net profit margin | -973.01 | 77.83% |
Earnings per share | — | — |
EBITDA | -5.28M | -33.70% |
Effective tax rate | -0.19% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | — | — |
Total assets | — | — |
Total liabilities | — | — |
Total equity | — | — |
Shares outstanding | — | — |
Price to book | — | — |
Return on assets | — | — |
Return on capital | — | — |
Cash Flow
Net change in cash
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -5.32M | 12.84% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2004
Website
Employees
54
